Штрих-коды для клинических испытаний: этикетки для слепого метода и рандомизации

Clinical Trial Barcodes: Blinding & Randomization Labels

Clinical trials depend on barcode labeling for maintaining study integrity, managing investigational products, and ensuring regulatory compliance. Barcodes enable blinded labeling, randomization tracking, and complete audit trails for Good Clinical Practice (GCP).

Blinded Trial Labels

In double-blind studies, neither the patient nor the investigator knows whether the patient receives the active drug or placebo. Barcodes support blinding by:

• Encoding a randomization number rather than the drug identity
• Using identical labels for active and placebo packages
• Enabling emergency unblinding through the barcode link to randomization tables

Barcode Data Elements

Clinical trial package barcodes typically encode:

Sensitive data (treatment group, drug identity) is stored only in the secure randomization system, not in the barcode.

Interactive Response Technology (IRT)

The IRT system manages drug supply and randomization:

1. Patient enrolled and randomized
2. IRT assigns a kit number
3. Investigator scans the kit barcode to confirm assignment
4. IRT verifies the correct kit is being dispensed
5. System tracks drug accountability (dispensed, returned, destroyed)

Regulatory Requirements

GCP and regulatory requirements for clinical trial labeling:

• 21 CFR 312.6 (US): Investigational drug labeling requirements
• EU Annex 13: GMP for investigational medicinal products
• ICH E6: Good Clinical Practice documentation requirements

Barcodes must maintain readable audit trails for regulatory inspections.

Supply Chain Challenges

Clinical trial supply is uniquely complex:

• Small batch sizes with short shelf lives
• International shipping to multiple investigator sites
• Temperature-controlled logistics
• Blinded packaging preventing visual identification
• Country-specific labeling requirements

Barcodes are the primary tool for managing this complexity, ensuring the right kit reaches the right site for the right patient.

Unblinding Procedure

In case of a medical emergency, the barcode enables emergency unblinding:

1. Investigator scans the medication barcode
2. Contacts the IRT system with the encoded kit number
3. Medical monitor authorizes the unblinding
4. IRT reveals the treatment assignment for that specific patient
5. Clinical decision made based on the revealed treatment
6. Unblinding event is logged and reported to the sponsor and IRB

Implementation Best Practices

• Use tamper-evident labels to prevent unauthorized label swaps
• Verify barcode readability after packaging (cold chain exposure may affect adhesion)
• Maintain barcode-to-randomization mapping in a validated, 21 CFR Part 11 compliant system
• Include backup human-readable randomization numbers on labels
• Train site staff on barcode scanning procedures and error handling